110 related articles for article (PubMed ID: 6894886)
1. Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma cells.
Nicholson ML; Voris BP; Young DA
Cancer Res; 1981 Sep; 41(9 Pt 1):3530-7. PubMed ID: 6894886
[TBL] [Abstract][Full Text] [Related]
2. Development of resistance to glucocorticoid hormones during rat thymus cell differentiation: proteins associated with emergence of the resistant state.
Voris BP; Nicholson ML; Young DA
Cancer Res; 1983 Mar; 43(3):1236-43. PubMed ID: 6825095
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
Nicholson ML; Young DA
Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273
[TBL] [Abstract][Full Text] [Related]
4. Independence of the lethal actions of glucocorticoids on lymphoid cells from possible hormone effects on calcium uptake.
Nicholson ML; Young DA
J Supramol Struct; 1979; 10(2):165-74. PubMed ID: 582325
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
Kaiser N; Milholland RJ; Rosen F
Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
[No Abstract] [Full Text] [Related]
6. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
Davis JM; Chan AK; Thompson EA
J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
[TBL] [Abstract][Full Text] [Related]
7. Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798.
Behrens UJ; Hollander VP
Cancer Res; 1976 Jan; 36(1):172-80. PubMed ID: 946164
[TBL] [Abstract][Full Text] [Related]
8. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
McPartland RP; Milholland RJ; Rosen F
Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.
Thompson EA; Moore WM; Sawyer RH
J Natl Cancer Inst; 1980 Aug; 65(2):477-83. PubMed ID: 6931263
[TBL] [Abstract][Full Text] [Related]
10. Selection and biologic properties of malignant variants of a murine lymphosarcoma.
Brunson KW; Nicolson GL
J Natl Cancer Inst; 1978 Dec; 61(6):1499-503. PubMed ID: 281557
[TBL] [Abstract][Full Text] [Related]
11. Early effects of glucocorticoid treatment on amino acid metabolism in lymphosarcoma P1798.
Stevens J; Stevens YW; Hollander VP
Cancer Res; 1973 Feb; 33(2):370-4. PubMed ID: 4739450
[No Abstract] [Full Text] [Related]
12. Differences in cell surface characteristics between glucocorticoid-sensitive and -resistant mouse lymphomas.
Behrens UJ; Mashburn LT; Stevens J; Hollander VP; Lampen N
Cancer Res; 1974 Nov; 34(11):2926-32. PubMed ID: 4138432
[No Abstract] [Full Text] [Related]
13. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions.
Ip MM; Shea WK; Sykes D; Young DA
Cancer Res; 1991 Jun; 51(11):2786-96. PubMed ID: 1674446
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium butyrate on glucocorticoid-sensitive and -resistant P1798 lymphosarcoma.
Chang YF; Wu LH; Liu TY; Yang JC; Chi CW
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):1-5. PubMed ID: 1312378
[TBL] [Abstract][Full Text] [Related]
15. Selection and in vivo properties of lectin-attachment variants of malignant murine lymphosarcoma cell lines.
Reading CL; Belloni PN; Nicolson GL
J Natl Cancer Inst; 1980 May; 64(5):1241-9. PubMed ID: 6929022
[No Abstract] [Full Text] [Related]
16. In vitro binding of cortisol-1,2-3H by a substance in the supernatant fraction of P1798 mouse lymphosarcoma.
Hollander N; Chiu YW
Biochem Biophys Res Commun; 1966 Nov; 25(3):291-7. PubMed ID: 6013253
[No Abstract] [Full Text] [Related]
17. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
Lucas KL; Barbour KW; Housley PR; Thompson EA
Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
[TBL] [Abstract][Full Text] [Related]
18. Animal model of drug-resistant tumor progression.
Mironova N; Shklyaeva O; Andreeva E; Popova N; Kaledin V; Nikolin V; Vlassov V; Zenkova M
Ann N Y Acad Sci; 2006 Dec; 1091():490-500. PubMed ID: 17341638
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
Chi CW; Sykes D; Ip MM
Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype.
Chen G; Teicher BA; Frei E
Cancer Biochem Biophys; 1998 Jun; 16(1-2):139-55. PubMed ID: 9923973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
